RAZADYNE Trademark

Trademark Overview

On Tuesday, February 15, 2005, a trademark application was filed for RAZADYNE with the United States Patent and Trademark Office. The USPTO has given the RAZADYNE trademark a serial number of 78567650. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, September 1, 2016. This trademark is owned by Johnson & Johnson. The RAZADYNE trademark is filed in the Pharmaceutical Products category with the following description:

human pharmaceutical for the treatment of central nervous system diseases and disorders
razadyne

General Information

Serial Number78567650
Word MarkRAZADYNE
Filing DateTuesday, February 15, 2005
Status800 - REGISTERED AND RENEWED
Status DateThursday, September 1, 2016
Registration Number3118357
Registration DateTuesday, July 18, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2005

Trademark Statements

Goods and Serviceshuman pharmaceutical for the treatment of central nervous system diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 28, 2005
Primary Code005
First Use Anywhere DateTuesday, May 3, 2005
First Use In Commerce DateTuesday, May 3, 2005

Trademark Owner History

Party NameJohnson & Johnson
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 089337001

Trademark Events

Event DateEvent Description
Thursday, September 1, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, September 1, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, September 1, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, September 1, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 10, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 10, 2016TEAS SECTION 8 & 9 RECEIVED
Saturday, July 18, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, May 20, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 20, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 26, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, June 26, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, June 25, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 19, 2012TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 19, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 18, 2006REGISTERED-PRINCIPAL REGISTER
Thursday, June 1, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, May 26, 2006ASSIGNED TO LIE
Friday, May 19, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 3, 2006STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 11, 2006USE AMENDMENT FILED
Tuesday, April 11, 2006PAPER RECEIVED
Tuesday, February 7, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 15, 2005PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2005NOTICE OF PUBLICATION
Tuesday, September 20, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 16, 2005ASSIGNED TO LIE
Tuesday, September 13, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 12, 2005ASSIGNED TO EXAMINER
Monday, February 28, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

razadyne system diseases disorders nervous central pharmaceutical treatment human